Cargando…
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects
Recently, mesenchymal stromal cell (MSC)-based therapy has become an appreciated therapeutic approach in the context of neurodegenerative disease therapy. Accordingly, a myriad of studies in animal models and also some clinical trials have evinced the safety, feasibility, and efficacy of MSC transpl...
Autores principales: | Rahbaran, Mohaddeseh, Zekiy, Angelina Olegovna, Bahramali, Mahta, Jahangir, Mohammadsaleh, Mardasi, Mahsa, Sakhaei, Delaram, Thangavelu, Lakshmi, Shomali, Navid, Zamani, Majid, Mohammadi, Ali, Rahnama, Negin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287902/ https://www.ncbi.nlm.nih.gov/pubmed/35842587 http://dx.doi.org/10.1186/s11658-022-00359-z |
Ejemplares similares
-
Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach
por: Yari, Hadi, et al.
Publicado: (2022) -
Optimizing sgRNA to Improve CRISPR/Cas9 Knockout Efficiency: Special Focus on Human and Animal Cell
por: Shojaei Baghini, Sadegh, et al.
Publicado: (2021) -
Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2
por: Ghaebi, Mahnaz, et al.
Publicado: (2021) -
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
por: Mardi, Amirhossein, et al.
Publicado: (2022) -
Psychometric Validation of the Persian Version of the COVID-19-Related Psychological Distress Scale and Association with COVID-19 Fear, COVID-19 Anxiety, Optimism, and Lack of Resilience
por: Nazari, Nabi, et al.
Publicado: (2021)